O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1 +$52.4M
2 +$48.2M
3 +$38.6M
4
ASND icon
Ascendis Pharma
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1 +$105M
2 +$93.6M
3 +$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
1
Edgewise Therapeutics
EWTX
$3.22B
$252M 6.04%
15,518,492
BSX icon
2
Boston Scientific
BSX
$114B
$237M 5.69%
2,429,300
-383,900
LLY icon
3
Eli Lilly
LLY
$992B
$230M 5.51%
301,200
-36,400
SVA
4
DELISTED
Sinovac Biotech, Ltd
SVA
$184M 4.42%
2,718,735
ELVN icon
5
Enliven Therapeutics
ELVN
$1.76B
$163M 3.91%
7,959,538
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$44.2B
$138M 3.3%
301,600
-40,300
SYK icon
7
Stryker
SYK
$148B
$133M 3.18%
359,200
EW icon
8
Edwards Lifesciences
EW
$50.2B
$131M 3.14%
1,684,000
-24,000
ISRG icon
9
Intuitive Surgical
ISRG
$179B
$128M 3.08%
287,200
-3,800
ARGX icon
10
argenx
ARGX
$47.5B
$127M 3.05%
172,300
-35,700
SION
11
Sionna Therapeutics
SION
$1.63B
$109M 2.61%
3,704,959
UPB
12
Upstream Bio Inc
UPB
$415M
$107M 2.57%
5,693,589
IRON icon
13
Disc Medicine
IRON
$2.51B
$93.5M 2.24%
1,415,020
CAI
14
Caris Life Sciences
CAI
$5.68B
$91.8M 2.2%
3,034,858
SPRY icon
15
ARS Pharmaceuticals
SPRY
$917M
$83.3M 2%
8,288,510
RNAM
16
Avidity Biosciences
RNAM
$11.2B
$71.4M 1.71%
1,638,886
-174,000
MBX
17
MBX Biosciences
MBX
$1.46B
$70.1M 1.68%
4,002,887
CGON icon
18
CG Oncology
CGON
$4.86B
$69.6M 1.67%
1,726,850
-151,000
NTRA icon
19
Natera
NTRA
$29B
$69.1M 1.66%
429,300
-164,134
AXSM icon
20
Axsome Therapeutics
AXSM
$8.38B
$64.6M 1.55%
531,800
+103,900
TERN icon
21
Terns Pharmaceuticals
TERN
$4.58B
$56.8M 1.36%
7,562,971
AVBP icon
22
ArriVent BioPharma
AVBP
$948M
$55.9M 1.34%
3,027,328
MLYS icon
23
Mineralys Therapeutics
MLYS
$2.32B
$55.7M 1.34%
1,469,494
+709,143
EXAS icon
24
Exact Sciences
EXAS
$19.7B
$54.4M 1.31%
994,616
+387,300
CMPX icon
25
Compass Therapeutics
CMPX
$1B
$53.3M 1.28%
15,219,994